Expression, Purification, and Validation of Anthrax Toxin Proteins


Expression, purification, and validation of anthrax toxin proteins.

Potential Commercial Applications: Competitive Advantages:
  • A research material that can be used in the development of assays, validation of products or in quality control.
 
  • Speed up product development with NIH developed material that has already been tested and validated.


Inventors:

Rasem Fattah (NIAID)  ➽ more inventions...

Stephen Leppla (NIAID)  ➽ more inventions...


Intellectual Property:
Research Material – Patent protection is not being pursued for this technology. (IC Reference No. 2015-019)

Licensing Contact:
Wade Green,
Email: wade.green@nih.gov
Phone: 301-761-7505

OTT Reference No: E-201-2015-0
Updated: Jun 7, 2018